IL140054D0 - Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy (ies) and surfactant depletion - Google Patents

Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy (ies) and surfactant depletion

Info

Publication number
IL140054D0
IL140054D0 IL14005400A IL14005400A IL140054D0 IL 140054 D0 IL140054 D0 IL 140054D0 IL 14005400 A IL14005400 A IL 14005400A IL 14005400 A IL14005400 A IL 14005400A IL 140054 D0 IL140054 D0 IL 140054D0
Authority
IL
Israel
Prior art keywords
bronchoconstriction
ies
allergy
kit
compositions
Prior art date
Application number
IL14005400A
Original Assignee
Univ East Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12795899P priority Critical
Application filed by Univ East Carolina filed Critical Univ East Carolina
Priority to PCT/US2000/008020 priority patent/WO2000062736A2/en
Publication of IL140054D0 publication Critical patent/IL140054D0/en

Links

IL14005400A 1999-04-06 2000-03-24 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy (ies) and surfactant depletion IL140054D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12795899P true 1999-04-06 1999-04-06
PCT/US2000/008020 WO2000062736A2 (en) 1999-04-06 2000-03-24 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion

Publications (1)

Publication Number Publication Date
IL140054D0 true IL140054D0 (en) 2002-02-10

Family

ID=22432865

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14005400A IL140054D0 (en) 1999-04-06 2000-03-24 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy (ies) and surfactant depletion

Country Status (8)

Country Link
EP (1) EP1168919A4 (en)
JP (1) JP2003515525A (en)
CN (1) CN1330513A (en)
AU (1) AU4031700A (en)
BR (1) BR0006019A (en)
CA (1) CA2330022A1 (en)
IL (1) IL140054D0 (en)
WO (1) WO2000062736A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730477B1 (en) 1998-08-04 2004-05-04 Diadexus, Inc. Method of diagnosing, monitoring and staging breast cancer
US6737040B1 (en) 1998-08-04 2004-05-18 Diadexus, Inc. Method and antibody for imaging breast cancer
AU3766900A (en) * 1999-03-26 2000-10-16 Human Genome Sciences, Inc. 47 human secreted proteins
DE10049549A1 (en) * 2000-10-06 2002-05-02 Markus Hecker Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40
WO2003004511A2 (en) 2001-07-06 2003-01-16 Topigen Pharmaceutique Inc.. Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
WO2004086052A2 (en) * 2003-03-28 2004-10-07 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a2b (adora2b)
US7671182B2 (en) * 2003-03-31 2010-03-02 Council Of Scientific & Industrial Research Gene variants of signal transducer and activator of transcription-6 (STAT 6) variants and process of detection the same
WO2006010492A1 (en) * 2004-07-28 2006-02-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with tryptase 1 (tps1)
US7485468B2 (en) 2004-10-15 2009-02-03 Galapagos Bv Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
US8673268B2 (en) 2004-10-15 2014-03-18 Galapagos N.V. Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
CA2584614A1 (en) * 2004-10-20 2006-08-24 Antisense Therapeutics Ltd Antisense modulation of integrin .alpha.4 expression
NZ554723A (en) 2004-10-29 2009-12-24 Topigen Pharmaceuticals Inc Antisense oligonucleotides against CCR3 chemokine receptor
CA2587903A1 (en) 2004-11-17 2006-05-26 Amgen Fremont Inc. Fully human monoclonal antibodies to il-13
US8592384B2 (en) 2005-04-04 2013-11-26 The Board Of Regents Of The University Of Texas System Micro-RNA's that regulate muscle cells
WO2008021237A1 (en) * 2006-08-10 2008-02-21 Arubor Corporation Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
US8426581B2 (en) * 2009-03-27 2013-04-23 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of the FCεR1α gene

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE637965T1 (en) * 1991-11-26 1995-12-14 Gilead Sciences Inc Increased formation of triple and double helices of oligomers having modified pyrimidines.
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5320962A (en) * 1992-07-22 1994-06-14 Duke University DNA encoding the human A1 adenosine receptor
US5801154A (en) * 1993-10-18 1998-09-01 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of multidrug resistance-associated protein
US5994315A (en) * 1995-06-07 1999-11-30 East Carolina University Low adenosine agent, composition, kit and method for treatment of airway disease
US6025339A (en) * 1995-06-07 2000-02-15 East Carolina University Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
US6040296A (en) * 1995-06-07 2000-03-21 East Carolina University Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
CA2236825A1 (en) * 1995-11-21 1997-05-29 Icn Pharmaceuticals, Inc. Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor
US5856462A (en) * 1996-09-10 1999-01-05 Hybridon Incorporated Oligonucleotides having modified CpG dinucleosides
EP1009413B1 (en) * 1997-09-05 2007-02-14 The Regents Of The University Of California Use of immunostimulatory oligonucleotides for preventing or treating asthma
CA2333087C (en) * 1998-05-21 2014-07-08 Isis Pharmaceuticals Inc. Compositions and methods for the pulmonary delivery of nucleic acids
CN1317009A (en) * 1998-08-03 2001-10-10 东卡罗来纳大学 Low adenosine anti-sense oligonucleotide agent, composition, reagent kit and treatments

Also Published As

Publication number Publication date
AU4031700A (en) 2000-11-02
CN1330513A (en) 2002-01-09
JP2003515525A (en) 2003-05-07
EP1168919A2 (en) 2002-01-09
WO2000062736A2 (en) 2000-10-26
BR0006019A (en) 2001-03-13
EP1168919A4 (en) 2002-03-06
CA2330022A1 (en) 2000-10-26
WO2000062736A3 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
GB2393734B (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
TW575693B (en) Electroplating composition and method of using
HRP990195A2 (en) Intranasal formulations for the treatment of sexual disorders
AU7604801A (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
PL364919A1 (en) Matchable low-e i.g. units and laminates and methods of making same
ZA200409387B (en) Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
AU2001261474A1 (en) Compositions and methods for the treatment of cancer
AU7928401A (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
EP1231887A4 (en) Method and composition for the treatment of scars
MXPA03007816A (en) Disposable underpants and method of providing the same.
AU2002335635A1 (en) Topical compositions and methods for treating pain
GB2421434B (en) Compositions And Methods For Treating Gynaecological Disorders
AU2003279010A1 (en) Compositions and methods for delivery of short interfering rna and short hairpin rna
EP1093363A4 (en) Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
WO2002102313A3 (en) Pyrimidine inhibitors of phosphodiesterase (pde) 7
SI1073658T1 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
AU7604400A (en) Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
HK1158493A1 (en) Hair treatment agent composition and method for production thereof
IL187513D0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
IL166241A (en) 2,4-pyrimidinediamine compounds for use in the treatment of autoimmune diseases
GB0007193D0 (en) Treatment of movrmrnt disorders
GB2351661B (en) Novel method of treatment
EP1679967A4 (en) Methods of using and compositions comprising selective cytokine inhibitory drus for treatment, modification and management of pain
AU2085201A (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death